Invention Grant
- Patent Title: Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
-
Application No.: US15501226Application Date: 2015-07-31
-
Publication No.: US10683293B2Publication Date: 2020-06-16
- Inventor: Sanne Schrøder Glad , Niels Grøn Nørager , Ian Sarvary , Alex Haahr Gouliaev , Lene Teuber , Luigi Piero Stasi
- Applicant: NUEVOLUTION A/S
- Applicant Address: DK Copenhagen
- Assignee: NUEVOLUTION A/S
- Current Assignee: NUEVOLUTION A/S
- Current Assignee Address: DK Copenhagen
- Agency: Marshall, Gerstein & Borun LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6e8205a5 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@51b92978
- International Application: PCT/EP2015/067692 WO 20150731
- International Announcement: WO2016/020288 WO 20160211
- Main IPC: C07D417/12
- IPC: C07D417/12 ; C07D413/12 ; C07D411/12 ; C07D409/14 ; C07D405/14 ; C07D239/48 ; C07D405/12 ; C07D403/14 ; C07D401/12 ; C07D401/14 ; C07D409/12 ; C07D487/04 ; C07D403/12 ; C07D413/14 ; C07D403/04 ; C07D413/04 ; C07D417/14 ; C07D451/04 ; C07D471/10 ; C07D401/04 ; C07D471/04
Abstract:
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
Public/Granted literature
Information query
